$STRW

Strawberry Fields REIT (STRW) Q2 2026 Earnings Call Transcript

Strawberry Fields REIT (STRW) held its Q2 2026 earnings call. For the first six months of 2026, revenue rose to $80 million (+6.4%) and net income was $18.4 million. AFFO was $73.9 million, with projected 10.1% AFFO growth per share in 2026. The company reported 100% rent collection, $300 million credit facility, and a $0.17 Q3 dividend.

Original reporting
Published Aug 14, 2026, 3:00 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 14, 2026, 3:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Strawberry Fields REIT (STRW) Q2 2026 Earnings Call Transcript — source image
Decision brief

The 30-second read

$STRWBullishMed
01

Why it matters

Investors get concrete operating metrics (rent collection, occupancy, lease duration), capital structure details (new $300M credit facility, leverage target), and a specific acquisition pipeline ($225M active opportunities) that inform near-term valuation and underwriting assumptions.

02

Market read

The call supplies fresh, modelable inputs for REIT income and growth: projected 10.1% AFFO growth per share in 2026, 100% rent collection, 77% occupancy, and a $300M credit facility supporting a $225M pipeline.

03

What to watch

The transcript highlights elevated G&A from one-time loan costs and a 77% occupancy level; traders may underweight how occupancy and transition risk could affect future rent coverage and AFFO durability.

Relevance 7/10Novelty 6/10Timing: post-earnings call, same-day modeling for 2026 AFFO and acquisition funding

Background

The article is a transcript of Strawberry Fields REIT’s Q2 2026 earnings call, covering first-half 2026 results, 2026 outlook, portfolio metrics, and financing plans.

Company-level read

Ticker impact

$STRWBullishMedium confidence
Context

Strawberry Fields REIT reported Q2 2026 results and disclosed 2026 AFFO growth of 10.1% per share plus a $300M credit facility and $225M pipeline.

Expected impact

Moderately positive bias for the stock, with upside skew if investors believe the 4Q deal cadence and 10.1% AFFO growth are credible.

Evidence & confidence

Key disclosed datapoints include AFFO $73.9M, projected 10.1% AFFO growth for 2026, 100% rent collection, occupancy at 77%, and a $300M corporate credit facility with ~50% target net debt to assets. These are decision-relevant for income and growth modeling, though the transcript is not a surprise earnings beat/miss narrative in the provided text.

Market effects

Reinforces skilled nursing REIT underwriting themes: master-lease structure, rent collection discipline, and cap-rate discipline at ~10%.

Kansas City hospital campus acquisition is a localized growth signal, but the article does not provide broader regional demand data.

Limited global relevance; the Israel shekel-denominated debt strategy is a specific balance-sheet hedge rather than a macro driver.

Counterpoint

Management frames 2026 as a slow growth year due to “wonky” deal cycles, and most closings are pushed into 4Q, which can increase execution risk versus the AFFO growth target.

Key entities

  • Strawberry Fields REIT, Inc.

    Skilled nursing REIT reporting Q2 2026 results and providing 2026 AFFO growth guidance, financing capacity, and acquisition pipeline details.

  • Moishe Gubin

    Chairman and CEO who discussed 2026 deal-cycle slowness, valuation discount, and debt strategy.

  • Greg Flamion

    CFO who covered financial metrics and credit facility structure.

  • Jeffrey Bajtner

    CIO who discussed AFFO and deal pipeline expectations.

Related articles

$STRWMed

Strawberry Fields REIT Q2 Earnings Call Highlights

Strawberry Fields REIT (STRW) reported Q2 adjusted funds from operations (AFFO) of $73.9 million and projected 10.1% AFFO-per-share growth. It posted adjusted EBITDA of $135.7 million, 14.4% lease yield, and net debt to net assets of 49.8%. The board approved a $0.17 quarterly dividend. The company closed a $300 million credit facility and contracted to buy a Missouri hospital campus for $10.4 million.

Med

Green Thumb Industries: Is This Profitable Cannabis Stock Still Undervalued?

Green Thumb Industries (GTBIF) reported Q2 revenue of $306.7M, EBITDA of $84.3M, and net income of $4.9M. The company grew revenue by 4.6% YoY and maintains a strong balance sheet with $283.6M in cash and $283M in debt. It repurchased 7.9M shares in Q2. Despite challenges, its financial flexibility and potential federal reform make it a notable player in the cannabis industry.

$MDTMedAI 8/10

Can Medtronic’s (MDT) Core Units Keep Up With Management’s New Bets?

Medtronic (MDT) reported strong Q1 results, raising its fiscal 2027 revenue growth outlook to 7.25-7.75%. The company is investing in high-growth areas like robotic surgery and partnerships, such as a $700M deal for Cornerstone's Sentire Surgical System. However, it faces stiff competition from peers like Johnson & Johnson and Intuitive Surgical. Institutional investors, including BlackRock, are increasing their stakes in MDT.

$CTASHighAI 8/10

Cintas Reports Record $3.01 Billion In Q1 Revenue And Raises Fiscal 2027 Outlook

Cintas reported Q1 revenue of $3.01B, up 8.9% organically, with net income rising 12.3% to $551.7M. Gross margin improved to 51.5%. The company raised fiscal 2027 revenue guidance to $12.15B-$12.27B and adjusted diluted earnings to $5.45-$5.54 per share, excluding UniFirst acquisition effects. Cintas also returned $753.5M to shareholders via dividends and stock repurchases.

$PAYXHighAI 9/10

Paychex Reports $1.63 Billion In Q1 Revenue As Net Income Increases 12% To $429.7 Million

Paychex reported Q1 2027 revenue of $1.63B, up 6% YoY, with net income rising 12% to $429.7M. Growth was driven by payroll, human capital management, and PEO businesses. Operating income increased 14% to $619.2M, while operating margin improved to 38%. The company also reported higher interest income and reduced acquisition-related expenses. Paychex declared $423.6M in dividends and has a $1B share repurchase program.